Yoshitsugu Shitaka
President & Chief Executive Officer RealizeEdge Partners
Dr. Yoshitsugu Shitaka is the former Chief Scientific Officer at Astellas Pharma, where he led global research efforts in regenerative medicine, targeted protein degradation, and immuno-oncology. He earned his B.S., M.S., and Ph.D. in Pharmaceutical Sciences from the University of Tokyo and has over 25 years of industry experience
Seminars
Thursday 26th February 2026
Dual, DAC, & Novel: Do We Need More Targets or More Payloads?
3:40 pm
- Evaluating the value of payloads beyond Tubulin and Topoisomerases and why novel payload approaches will hold potential to overcome drug resistance
- What are the challenges when doing something different and how are we decreasing risk when translating preclinical optimism into clinical success
- Specifically thinking about DACs, what is it about small molecule degraders that lend themselves to making good payloads?
- Discussing the panelists approach to business development. What would a win/win business deal look like that focuses on payloads?
